Here is a seemingly nicely written article about the application of targeted oligo delivery conjugation therapies.
With a deal and a debut, targeted oligo delivery gets a boost from ADCs
We have actually reported on both of these before, but its always nice when a real journalist does some journalism. (This blog has never, and will never claim to be real journalism)
https://www.adcdaily.com/2019/04/lilly-taps-aviditys-antibody.html
No comments:
Post a Comment